AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1543592 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp exercise test at different rates of increasing work rate (protocol 2)
Number of subjects: 17
Study 1543592 — intervention group
Group type: COMPARATOR
Intervention: Control days (days 1 and 3 in protocol 1)
Number of subjects: 17
Study 3161703 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal once daily (500 mg or 1000 mg)
Number of subjects: 235
Study 3161703 — intervention group
Group type: COMPARATOR
Intervention: Diflunisal twice daily
Number of subjects: 235
Study 30878794 — intervention group
Group type: EXPERIMENTAL
Intervention: Full vouchers and conditional cash transfers
Number of subjects: 0
Study 30878794 — intervention group
Group type: COMPARATOR
Intervention: Neither vouchers nor cash transfers
Number of subjects: 0
Study 30878794 — intervention group
Group type: EXPERIMENTAL
Intervention: Voucher without cash transfer
Number of subjects: 0
Study 30878794 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconditional cash transfer
Number of subjects: 0
Study 30878794 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messages
Number of subjects: 0
Study 30878794 — intervention group
Group type: EXPERIMENTAL
Intervention: Government policy to eliminate user fees
Number of subjects: 0
Study 29742258 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Bleaching 10% containing potassium oxalate
Number of subjects: 25
Study 29742258 — intervention group
Group type: COMPARATOR
Intervention: Opalescence 10%
Number of subjects: 25
Study 29742258 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale and CoVAS
Number of subjects: 25
Study 29742258 — intervention group
Group type: EXPERIMENTAL
Intervention: TSA II
Number of subjects: 25
Study 26341327 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver strain assessed with the Caregiver Strain Index (CSI)
Number of subjects: 126
Study 26341327 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient functional status
Number of subjects: 126
Study 26341327 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient emotional functioning
Number of subjects: 126
Study 26341327 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver passive coping style
Number of subjects: 126
Study 26341327 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver symptoms of anxiety
Number of subjects: 126
Study 26341327 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver perceived quality of care
Number of subjects: 126
Study 24594361 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult passenger providing driving tips
Number of subjects: 3
Study 24594361 — intervention group
Group type: COMPARATOR
Intervention: Silent adult passenger
Number of subjects: 3
Study 24594361 — intervention group
Group type: COMPARATOR
Intervention: Driving alone
Number of subjects: 3
Study 22098541 — intervention group
Group type: EXPERIMENTAL
Intervention: RD-CODOX-M/IVAC regimen with rituximab and liposome-encapsulated cytarabine
Number of subjects: 30
Study 22098541 — intervention group
Group type: EXPERIMENTAL
Intervention: RD-CODOX-M/IVAC regimen
Number of subjects: 30
Study 20924215 — intervention group
Group type: EXPERIMENTAL
Intervention: Clevudine 30 mg daily
Number of subjects: 92
Study 20924215 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 100 mg daily
Number of subjects: 92
Study 17650294 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepimmune vaccine (four injections in 2 weeks intervals)
Number of subjects: 15
Study 17650294 — intervention group
Group type: COMPARATOR
Intervention: Standard HBV vaccine (HBVAXPRO)
Number of subjects: 15
Study 16084873 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic diagnosis (PGD)
Number of subjects: 301
Study 16084873 — intervention group
Group type: COMPARATOR
Intervention: Comparison group of women undergoing PGD for advanced maternal age (> or =35 years)
Number of subjects: 301
Study 12182370 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand gel with multifaceted quality improvement (QI) interventions
Number of subjects: 62
Study 12182370 — intervention group
Group type: COMPARATOR
Intervention: Standard handwashing and glove use
Number of subjects: 62
Study 12182370 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand gel
Number of subjects: 62
Study 12182370 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand gel with QI support
Number of subjects: 62
Study 9476749 — intervention group
Group type: EXPERIMENTAL
Intervention: Late sleep deprivation (LSD) twice weekly during week 1 and 2 followed by LSD once weekly during week 3 and 4
Number of subjects: 44
Study 9476749 — intervention group
Group type: COMPARATOR
Intervention: Late sleep deprivation (LSD) once weekly
Number of subjects: 44
Study 9476749 — intervention group
Group type: EXPERIMENTAL
Intervention: Late sleep deprivation (LSD) twice weekly followed by once weekly
Number of subjects: 44
Study 7884117 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone (5 and 10 micrograms/kg/min)
Number of subjects: 14
Study 7884117 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (5 and 10 micrograms/kg/min)
Number of subjects: 14
Study 2146040 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with left ventricular dysfunction (no overt heart failure)
Number of subjects: 288
Study 2146040 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with overt heart failure
Number of subjects: 288
Study 2146040 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients on diuretic therapy
Number of subjects: 288
Study 2146040 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 288
Study 219471 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (diuretic therapy)
Number of subjects: 23
Study 31907833 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual trinitroglycerin (TNG)
Number of subjects: 132
Study 31907833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine (AD)
Number of subjects: 132
Study 31907833 — intervention group
Group type: COMPARATOR
Intervention: HUTT-negative patients
Number of subjects: 132
Study 31915072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous vitamin C (50 mg/kg every 6 h for 96 h)
Number of subjects: 800
Study 31915072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 31915072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous vitamin C
Number of subjects: 800
Study 30731195 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleot(s)ide analogue therapy
Number of subjects: 0
Study 27681658 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-Supported arm
Number of subjects: 1229
Study 27681658 — intervention group
Group type: COMPARATOR
Intervention: Patient Self-Directed Care arm
Number of subjects: 1229
Study 26460293 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 160 μg (80 μg × 2 inhalations) twice daily via pMDI
Number of subjects: 304
Study 26460293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study 23324079 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib in combination with TACE
Number of subjects: 304
Study 23324079 — intervention group
Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 304
Study 20666876 — intervention group
Group type: EXPERIMENTAL
Intervention: CO(2) laser therapy
Number of subjects: 191
Study 20666876 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy + intralesional meglumine antimoniate
Number of subjects: 191
Study 19803786 — intervention group
Group type: EXPERIMENTAL
Intervention: Citicoline (1000 mg twice a day)
Number of subjects: 1292
Study 19803786 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice a day)
Number of subjects: 1292
Study 17076839 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukoreduced blood transfusion
Number of subjects: 67
Study 17076839 — intervention group
Group type: COMPARATOR
Intervention: Nonleukoreduced blood transfusion
Number of subjects: 67
Study 15187173 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed family relationship quality
Number of subjects: 96
Study 15187173 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed family problem solving
Number of subjects: 96
Study 11689496 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group (attended two screening sessions)
Number of subjects: 7229
Study 11689496 — intervention group
Group type: COMPARATOR
Intervention: Control group (received conventional medical care)
Number of subjects: 7229
Study 11689496 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group
Number of subjects: 7229
Study 11689496 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 7229
Study 9177956 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus total sleep deprivation (TSD)
Number of subjects: 10
Study 9177956 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine alone
Number of subjects: 10
Study 8131470 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous irrigation suction catheter (Irri-cath)
Number of subjects: 20
Study 8131470 — intervention group
Group type: COMPARATOR
Intervention: Conventional intermittent suction catheter
Number of subjects: 20
Study 3304827 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-T-200 (CuT)
Number of subjects: 19821
Study 3304827 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiload-250 (ML)
Number of subjects: 19821
Study 3304827 — intervention group
Group type: EXPERIMENTAL
Intervention: Nova-T (NoT)
Number of subjects: 19821
Study 3304827 — intervention group
Group type: COMPARATOR
Intervention: All IUDs
Number of subjects: 19821
Study 30243062 — intervention group
Group type: EXPERIMENTAL
Intervention: Target group (mean arterial pressure (MAP) ≥ 90% of preoperative values)
Number of subjects: 101
Study 30243062 — intervention group
Group type: COMPARATOR
Intervention: No-Target group (more liberal intraoperative blood pressure management)
Number of subjects: 101
Study 30243062 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 101
Study 28967054 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (HA) coated SL-PLUS stem
Number of subjects: 51
Study 28967054 — intervention group
Group type: COMPARATOR
Intervention: Uncoated SL-PLUS stem
Number of subjects: 51
Study 28967054 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (HA-coated and uncoated)
Number of subjects: 51
Study 26174080 — intervention group
Group type: EXPERIMENTAL
Intervention: EMD/synthetic bone graft (SBG)
Number of subjects: 30
Study 26174080 — intervention group
Group type: COMPARATOR
Intervention: EMD
Number of subjects: 30
Study 25096315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior group therapy for back pain (CBT-BP), six sessions.
Number of subjects: 103
Study 25096315 — intervention group
Group type: COMPARATOR
Intervention: Unspecific occupational therapy sessions (control group).
Number of subjects: 103
Study 23010155 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized primary tumor xenograft model
Number of subjects: 20
Study 23010155 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 20
Study 23010155 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Number of subjects: 20
Study 20814330 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER (6 mg/d, flexible dosing 3-12 mg/d)
Number of subjects: 311
Study 20814330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 311
Study 18060972 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress urinary incontinence surgery
Number of subjects: 655
Study 15953743 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic MgSO4 (2.5 ml, 6.3%) + salbutamol (2.5 ml)
Number of subjects: 26
Study 15953743 — intervention group
Group type: COMPARATOR
Intervention: Saline (2.5 ml) + salbutamol (2.5 ml)
Number of subjects: 26
Study 11807630 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (45 mg oral administration)
Number of subjects: 18
Study 11807630 — intervention group
Group type: COMPARATOR
Intervention: Control group (no menatetrenone)
Number of subjects: 18
Study 10578913 — intervention group
Group type: EXPERIMENTAL
Intervention: German language RCTs
Number of subjects: 15
Study 10578913 — intervention group
Group type: COMPARATOR
Intervention: Hand search of nursing journals
Number of subjects: 15
Study 7751498 — intervention group
Group type: EXPERIMENTAL
Intervention: APSAC
Number of subjects: 21
Study 7751498 — intervention group
Group type: COMPARATOR
Intervention: Tissue-type plasminogen activator
Number of subjects: 21
Study 2189719 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid aerosol (with or without flavor additives)
Number of subjects: 0
Study 2189719 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid inhalers used throughout 8 hours of cigarette deprivation
Number of subjects: 0
Study 2189719 — intervention group
Group type: COMPARATOR
Intervention: Cigarette
Number of subjects: 0
Study 2189719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 378016 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 72
Study 378016 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine
Number of subjects: 72
Study 31336492 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 20
Study 31336492 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 20
Study 28152219 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic PEG tube
Number of subjects: 134
Study 28152219 — intervention group
Group type: COMPARATOR
Intervention: Common clinical nutritional support
Number of subjects: 134
Study 25663605 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ventral hernia repair (LVHR) with defect closure (transfascial sutures)
Number of subjects: 143
Study 25663605 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic ventral hernia repair (LVHR) without defect closure
Number of subjects: 143
Study 23507787 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical management + NT-proBNP monitoring
Number of subjects: 407
Study 23507787 — intervention group
Group type: COMPARATOR
Intervention: Clinical management
Number of subjects: 407
Study 21037266 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased workload during simulated critical incidents (sessions 2 and 3)
Number of subjects: 15
Study 21037266 — intervention group
Group type: COMPARATOR
Intervention: No critical incident simulated (session 1)
Number of subjects: 15
Study 19010347 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention group (n=24; 5 males) gradually increasing walking by 3000 steps/day on 5 days of the week.
Number of subjects: 48
Study 19010347 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=24; 6 males, no change in walking).
Number of subjects: 48
Study 19010347 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups measured for glucose, insulin, hsCRP, IL-6, sIL-6R, TNF-alpha, sTNFR1 and sTNFRII.
Number of subjects: 48
Study 17869634 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 18023
Study 17869634 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents
Number of subjects: 18023
Study 17869634 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 18023
Study 15149258 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing instructions previewing movements
Number of subjects: 0
Study 15149258 — intervention group
Group type: COMPARATOR
Intervention: Instructions following the movements
Number of subjects: 0
Study 15149258 — intervention group
Group type: COMPARATOR
Intervention: Participants' own movement mimicry
Number of subjects: 0
Study 16206668 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy and Fluoxetine (20mg once a day for 12 weeks)
Number of subjects: 76
Study 16206668 — intervention group
Group type: COMPARATOR
Intervention: Regular cardiac medicine therapy
Number of subjects: 76
Study 9486551 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 178
Study 9486551 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary open-angle glaucoma (POAG) patients
Number of subjects: 178
Study 9486551 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-tension glaucoma (NTG) patients
Number of subjects: 178
Study 8057649 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with vindesine (3 mg/m2 weekly x 5, then every 2 weeks x 8) and cisplatin (120 mg/m2 on days 1, 29, 71, 113) plus thoracic irradiation
Number of subjects: 72
Study 8057649 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 72
Study 8057649 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation
Number of subjects: 72
Study 2522134 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg of amlodipine
Number of subjects: 205
Study 2522134 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of amlodipine
Number of subjects: 205
Study 2522134 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of amlodipine
Number of subjects: 205
Study 2522134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 30891721 — intervention group
Group type: EXPERIMENTAL
Intervention: moodgym + treatment as usual (TAU)
Number of subjects: 647
Study 30891721 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual (TAU)
Number of subjects: 647
Study 28708316 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols supplementation (2.0 g free plant sterols equivalent of palmityl esters daily for 4 weeks)
Number of subjects: 18
Study 28708316 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18
Study 25044345 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable collagen‐based tetracycline fibers (Periodontal Plus AB fibers) adjunct to scaling and root planing
Number of subjects: 40
Study 25044345 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (monotherapy)
Number of subjects: 40
Study 23311889 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education plus supervised exercise (3 months, 12 sessions of individualized neuromuscular training, 12 sessions of intensive resistance training, and 3 sessions of patient education)
Number of subjects: 0
Study 23311889 — intervention group
Group type: COMPARATOR
Intervention: Patient education alone (3 sessions)
Number of subjects: 0
Study 23311889 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education plus supervised exercise
Number of subjects: 0
Study 23311889 — intervention group
Group type: COMPARATOR
Intervention: Patient education alone
Number of subjects: 0
Study 21591986 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental cheese (from milk produced by cows fed a grass and maize silage based diet with 5% of linseed oil added)
Number of subjects: 30
Study 21591986 — intervention group
Group type: COMPARATOR
Intervention: Control cheese (from normal cows' milk)
Number of subjects: 30
Study 18307489 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise support program (1 hour per week at the hospital and two sessions at home for 3 months)
Number of subjects: 80
Study 18307489 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 80
Study 16582045 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (titrated from 37.5 to 225 mg per day)
Number of subjects: 300
Study 16582045 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (titrated from 20 to 60 mg per day)
Number of subjects: 300
Study 16582045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 16582045 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 300
Study 16582045 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 300
Study 12619027 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular adsorbents recirculating system (MARS) treatment for 6 hours
Number of subjects: 13
Study 12619027 — intervention group
Group type: COMPARATOR
Intervention: Control group (mechanically cooled)
Number of subjects: 13
Study 10732888 — intervention group
Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 401
Study 10732888 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 401
Study 8626096 — intervention group
Group type: EXPERIMENTAL
Intervention: LEEP (149 patients)
Number of subjects: 639
Study 8626096 — intervention group
Group type: EXPERIMENTAL
Intervention: Excisional laser (145 patients)
Number of subjects: 639
Study 8626096 — intervention group
Group type: COMPARATOR
Intervention: LEEP
Number of subjects: 639
Study 8626096 — intervention group
Group type: COMPARATOR
Intervention: Excisional laser
Number of subjects: 639
Study 8626096 — intervention group
Group type: COMPARATOR
Intervention: Both arms (LEEP and excisional laser)
Number of subjects: 639
Study 8626096 — intervention group
Group type: COMPARATOR
Intervention: Classical management
Number of subjects: 639
Study 1596064 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of lidocaine
Number of subjects: 18
Study 1596064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6379506 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular gangliosides (40 mg/d) for 6 months
Number of subjects: 19
Study 6379506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31003921 — intervention group
Group type: EXPERIMENTAL
Intervention: Low serum uromodulin (SUMOD)
Number of subjects: 0
Study 29522203 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-EBV < 2300 copies/ml
Number of subjects: 208
Study 29522203 — intervention group
Group type: COMPARATOR
Intervention: Pre-EBV ≥ 2300 copies/ml
Number of subjects: 208
Study 26308287 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home test kit and educational material
Number of subjects: 60
Study 26308287 — intervention group
Group type: COMPARATOR
Intervention: Educational material only (Control)
Number of subjects: 60
Study 25274230 — intervention group
Group type: EXPERIMENTAL
Intervention: >80 °C hot water
Number of subjects: 60
Study 25274230 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic wipes
Number of subjects: 60
Study 25274230 — intervention group
Group type: COMPARATOR
Intervention: No disinfection (control group)
Number of subjects: 60
Study 22574590 — intervention group
Group type: EXPERIMENTAL
Intervention: Wenshen Huatan Recipe (WHR)
Number of subjects: 90